Lock out: targeting TMPRSS2 to block influenza and coronaviruses

Lu Zhang1,2, Markus Hoffmann1, Stefan Pöhlmann1,2

  • 1Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.

Insights

Transmembrane protease serine 2 (TMPRSS2) is crucial for activating coronaviruses and influenza A viruses (IAV). Targeting TMPRSS2 offers a promising strategy for developing new antiviral therapies against these respiratory pathogens.

Area of Science:

  • Virology
  • Biochemistry
  • Pharmacology

Background:

  • Coronaviruses and influenza A viruses (IAV) cause severe respiratory illness with pandemic potential.
  • Viral glycoprotein priming by host proteases is essential for infectivity, representing a key target for antiviral strategies.

Purpose of the Study:

  • To review the critical role of transmembrane protease serine 2 (TMPRSS2) in coronavirus and IAV priming.
  • To summarize recent advancements in understanding TMPRSS2 biology and its inhibition for therapeutic purposes.

Main Methods:

  • Literature review of studies on TMPRSS2 function in viral infections.
  • Analysis of research on the substrate specificity and pharmacological inhibition of TMPRSS2.

Main Results:

  • TMPRSS2 plays a central role in priming both coronavirus and IAV glycoproteins.
  • Extensive research, intensified by the COVID-19 pandemic, has elucidated TMPRSS2's function and potential as a therapeutic target.

Conclusions:

  • TMPRSS2 is a significant host dependency factor for coronaviruses and IAV.
  • Targeting TMPRSS2 presents a viable therapeutic avenue for combating infections caused by these viruses.

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
87
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.3K